Veroscience Drug Patent Portfolio

Veroscience owns 1 orange book drug protected by 22 US patents Given below is the list of Veroscience's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10688094 Bromocriptine formulations 30 Apr, 2032
Active
US11000522 Bromocriptine formulations 30 Apr, 2032
Active
US11666567 Bromocriptine formulations 30 Apr, 2032
Active
US8431155 Bromocriptine formulations 30 Apr, 2032
Active
US8613947 Bromocriptine formulations 30 Apr, 2032
Active
US9192576 Bromocriptine formulations 30 Apr, 2032
Active
US9522117 Bromocriptine formulations 30 Apr, 2032
Active
US9700555 Bromocriptine formulations 30 Apr, 2032
Active
US9993474 Bromocriptine formulations 30 Apr, 2032
Active
US10688155 Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders 07 Jun, 2030
Active
US8877708 Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders 07 Jun, 2030
Active
US9352025 Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders 07 Jun, 2030
Active
US9895422 Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders 07 Jun, 2030
Active
US7888310 Methods of identifying responders to dopamine agonist therapy 25 Jul, 2023 Expired
US8137992 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof 25 Jul, 2023 Expired
US8137993 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof 25 Jul, 2023 Expired
US8137994 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof 25 Jul, 2023 Expired
US5716957 Method for modifying and resetting the bloodstream prolactin levels of a human subject 10 Feb, 2015 Expired
US5679685 Accelerated release composition containing bromocriptine 21 Oct, 2014 Expired
US5468755 Therapeutic process for the treatment of the pathologies of Type II diabetes 21 Nov, 2012 Expired
US5756513 Therapeutic process for the treatment of the pathologies of type II diabetes 21 Nov, 2012 Expired
US5866584 Therapeutic process for the treatment of the pathologies of type II diabetes 21 Nov, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Veroscience.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 26 Dec, 2023 US10688094
Payment of Maintenance Fee, 4th Year, Large Entity 26 Dec, 2023 US10688155
Payment of Maintenance Fee, 12th Year, Large Entity 20 Sep, 2023 US8137993
Payment of Maintenance Fee, 12th Year, Large Entity 20 Sep, 2023 US8137992
Payment of Maintenance Fee, 12th Year, Large Entity 20 Sep, 2023 US8137994
Payment of Maintenance Fee, 8th Year, Large Entity 24 May, 2023 US9192576
Payment of Maintenance Fee, 12th Year, Large Entity 10 Oct, 2022 US7888310
11.5 yr surcharge- late pmt w/in 6 mo, Large Entity 10 Oct, 2022 US7888310
Maintenance Fee Reminder Mailed 03 Oct, 2022 US7888310
7.5 yr surcharge - late pmt w/in 6 mo, Large Entity 13 May, 2022 US8877708
Payment of Maintenance Fee, 8th Year, Large Entity 13 May, 2022 US8877708
Payment of Maintenance Fee, 4th Year, Large Entity 13 Dec, 2021 US9993474
Payment of Maintenance Fee, 4th Year, Large Entity 20 Aug, 2021 US9895422
Payment of Maintenance Fee, 8th Year, Large Entity 24 Jun, 2021 US8613947
Post Issue Communication - Certificate of Correction 16 Jun, 2021 US11000522


Veroscience's Family Patents

Veroscience drugs have patent protection in a total of 13 countries. It's US patent count contributes only to 49.0% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Veroscience Drug List

Given below is the complete list of Veroscience's drugs and the patents protecting them.


1. Cycloset

Cycloset is protected by 22 patents, out of which 9 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10688094 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US11000522 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US11666567 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US8431155 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US8613947 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US9192576 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US9522117 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US9700555 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US9993474 Bromocriptine formulations 30 Apr, 2032
(7 years from now)
Active
US10688155 Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders 07 Jun, 2030
(5 years from now)
Active
US8877708 Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders 07 Jun, 2030
(5 years from now)
Active
US9352025 Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders 07 Jun, 2030
(5 years from now)
Active
US9895422 Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders 07 Jun, 2030
(5 years from now)
Active
US7888310 Methods of identifying responders to dopamine agonist therapy 25 Jul, 2023
(1 year, 5 months ago)
Expired
US8137992 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof 25 Jul, 2023
(1 year, 5 months ago)
Expired
US8137993 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof 25 Jul, 2023
(1 year, 5 months ago)
Expired
US8137994 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof 25 Jul, 2023
(1 year, 5 months ago)
Expired
US5716957 Method for modifying and resetting the bloodstream prolactin levels of a human subject 10 Feb, 2015
(9 years ago)
Expired
US5679685 Accelerated release composition containing bromocriptine 21 Oct, 2014
(10 years ago)
Expired
US5468755 Therapeutic process for the treatment of the pathologies of Type II diabetes 21 Nov, 2012
(12 years ago)
Expired
US5756513 Therapeutic process for the treatment of the pathologies of type II diabetes 21 Nov, 2012
(12 years ago)
Expired
US5866584 Therapeutic process for the treatment of the pathologies of type II diabetes 21 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cycloset's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List